To select altered peptide ligands that might suppress arthritis, we used a panel of analog peptides containing substitutions at each position of the immunodominant DR4-restricted determinant of CII, replacing the wild-type residue with either alanine or the analogous amino acid present in type I collagen as we have done previously with DR1 molecules. This evidence concerns the gene TNFRSF10A and Arthritis.